Compare CRDF & CRMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRDF | CRMT |
|---|---|---|
| Founded | 1999 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.2M | 103.5M |
| IPO Year | 2012 | 2026 |
| Metric | CRDF | CRMT |
|---|---|---|
| Price | $1.91 | $12.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $9.63 | ★ $29.50 |
| AVG Volume (30 Days) | ★ 986.8K | 64.7K |
| Earning Date | 05-07-2026 | 06-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 27.37 | ★ 147.36 |
| EPS | ★ N/A | N/A |
| Revenue | $365,993.00 | ★ $1,390,932,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.92 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 49.61 | N/A |
| 52 Week Low | $1.48 | $10.58 |
| 52 Week High | $4.56 | $62.55 |
| Indicator | CRDF | CRMT |
|---|---|---|
| Relative Strength Index (RSI) | 57.95 | 51.19 |
| Support Level | $1.54 | $11.05 |
| Resistance Level | $2.05 | $13.56 |
| Average True Range (ATR) | 0.12 | 0.86 |
| MACD | 0.02 | 0.14 |
| Stochastic Oscillator | 67.09 | 72.27 |
Cardiff Oncology Inc is a clinical-stage biotechnology company that leverages PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies for various cancers with unmet medical needs. The company focuses on targeting tumor vulnerabilities with treatment combinations of onvansertib, its oral and selective PLK1 inhibitor, and standard-of-care (SoC) therapeutics. The firm's clinical program pipeline focuses on indications such as RAS-mutated metastatic colorectal cancer (mCRC), investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma (mPDAC), small cell lung cancer (SCLC), metastatic triple negative breast cancer (mTNBC), and Chronic Myelomonocytic Leukemia (CMML). Geographically, it operates only in the United States.
America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.